'What Matters With Liz' Episode 1: Henry Winkler, 80, on Why 'Pivoting Is Key to Living' (Exclusive) 'Happy Money' Episode 8: AARP Expert Reveals 6 Romance Scam Red Flags Women Need to Know About This content is not a substitute for professional medical advice or diagnosis
[PubMed] [Google Scholar] Seif S
Tirzepatide (brand name Mounjaro) is a dual GLP-1 and GIP receptor agonist that has demonstrated significant weight loss results in clinical trials, but its potency depends entirely on proper storage
My goal is to shed some light on what it actually feels like to be on one of these medications, sharing everything from what you can expect to what you should avoid
Deeper treatments are still comfortable, but we recommend opting for a topical anesthetic
Newer GLP-1 options Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, is in late-stage clinical trials and showing even greater weight loss potential than current options